Skip to main content
Smart Investors Daily
DM

NASDAQ · DMIIR

Drugs Made In America Acquisition II Corp. Right

Financial Services · Asset Management

$0.08

Down-$0.00 (-0.12%)

Updated Aug 15, 2026, 11:26 AM

SID Score

2.7/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
10.16M
P/E ratio
-54.87
Dividend yield
0.00%
52-week range
$0.06 – $0.11
Volume
17.91K
Avg. volume
776.48K

Price performance

DMIIR price history

1M range · 9 trading sessions · Daily adjusted prices

DMIIR closed at $0.08 after 9 trading sessions, up 0.00% for the selected period.

Last close
$0.08
Period change
+0.00%
Period low
$0.08
Period high
$0.09
Daily close
View OHLC price history
DMIIR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 14, 2026$0.0799$0.08$0.0785$0.0817.91K
Aug 11, 2026$0.0801$0.0801$0.0801$0.0801955
Aug 10, 2026$0.0822$0.0822$0.0822$0.0822503
Aug 4, 2026$0.09$0.09$0.08$0.0811.07K
Jul 29, 2026$0.08$0.08$0.08$0.082.1K
Jul 27, 2026$0.08$0.08$0.08$0.082.18K
Jul 24, 2026$0.09$0.09$0.08$0.08511.1K
Jul 23, 2026$0.08$0.08$0.08$0.082.11K
Jul 21, 2026$0.0808$0.0808$0.08$0.082.5K

Latest DMIIR news

The latest Smart Investors Daily articles mentioning DMIIR.

DMIIR research

Overview

Company profile and research snapshot.

Company profile

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.